Article
Clinical and Genetic Characterization of Patients with Artemis Deficiency in Japan.
Journal of clinical immunology - 1 Apr 2023
Inoue Kento, Miyamoto Satoshi, Tomomasa Dan, Adachi Eriko, Azumi Shohei, Horikoshi Yasuo, Ishihara Takashi, Osone Shinya, Kawahara Yuta, Kudo Ko, Kato Zenichiro, Ohnishi Hidenori, Kashimada Kenichi, Imai Kohsuke, Ohara Osamu, van Zelm Menno C, Cowan Morton J, Morio Tomohiro, Kanegane Hirokazu
Abstract excerpt
PURPOSE: Artemis is an exonuclease essential for V(D)J recombination and repair of DNA double-stranded breaks. Pathogenic variants in DCLRE1C encoding Artemis cause T-B-NK+ severe combined immunodeficiency (SCID), and patients with Artemis-deficient SCID (ART-SCID) require definitive therapy with allogeneic hematopoietic cell transplantation (HCT). Here we describe the clinical and genetic characteristics of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
